Thomas Frogne

1.3k total citations
11 papers, 557 citations indexed

About

Thomas Frogne is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Thomas Frogne has authored 11 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Genetics. Recurrent topics in Thomas Frogne's work include HER2/EGFR in Cancer Research (3 papers), Pancreatic function and diabetes (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Thomas Frogne is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Pancreatic function and diabetes (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Thomas Frogne collaborates with scholars based in Denmark, France and United States. Thomas Frogne's co-authors include Anne E. Lykkesfeldt, Anne‐Vibeke Lænkholm, Jan Stenvang, Rikke Vicki Benjaminsen, Zahra Azizi, Wufan Tao, Federico Paroni, Supreet Kaur, Amin Ardestani and Julie Kerr-Conte and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and PLoS ONE.

In The Last Decade

Thomas Frogne

11 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Frogne Denmark 9 313 217 149 108 92 11 557
Tongzhen Chen China 12 396 1.3× 317 1.5× 182 1.2× 135 1.3× 47 0.5× 22 819
Kevin J. Basile United States 10 434 1.4× 248 1.1× 57 0.4× 44 0.4× 51 0.6× 10 572
Natacha Bohin United States 9 318 1.0× 162 0.7× 64 0.4× 65 0.6× 44 0.5× 10 542
Marie-José Blivet-Van Eggelpoël France 7 473 1.5× 171 0.8× 55 0.4× 48 0.4× 47 0.5× 7 653
Huiying Zhi United States 12 372 1.2× 127 0.6× 77 0.5× 101 0.9× 59 0.6× 20 684
Anne Chotteau‐Lelièvre France 16 547 1.7× 175 0.8× 123 0.8× 30 0.3× 64 0.7× 21 749
Kathryn M. Kinross Australia 9 409 1.3× 158 0.7× 36 0.2× 50 0.5× 100 1.1× 16 632
Yang‐Min Xie China 13 412 1.3× 146 0.7× 45 0.3× 79 0.7× 99 1.1× 21 645
Awad Shamma Japan 12 395 1.3× 186 0.9× 106 0.7× 130 1.2× 59 0.6× 16 685
Prasad Kanteti United States 13 288 0.9× 190 0.9× 53 0.4× 31 0.3× 44 0.5× 15 511

Countries citing papers authored by Thomas Frogne

Since Specialization
Citations

This map shows the geographic impact of Thomas Frogne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Frogne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Frogne more than expected).

Fields of papers citing papers by Thomas Frogne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Frogne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Frogne. The network helps show where Thomas Frogne may publish in the future.

Co-authorship network of co-authors of Thomas Frogne

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Frogne. A scholar is included among the top collaborators of Thomas Frogne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Frogne. Thomas Frogne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Taebnia, Nayere, Firoz Babu Kadumudi, Thomas L. Andresen, et al.. (2021). Oxygen releasing hydrogels for beta cell assisted therapy. International Journal of Pharmaceutics. 602. 120595–120595. 15 indexed citations
2.
Ravassard, Philippe, Signe Ingvarsen, Marc Diedisheim, et al.. (2016). Xenotropic retrovirus Bxv1 in human pancreatic β cell lines. Journal of Clinical Investigation. 126(3). 1109–1113. 12 indexed citations
3.
Wernersson, Rasmus, Thomas Frogne, Claude Rescan, et al.. (2015). Analysis artefacts of the INS-IGF2 fusion transcript. BMC Molecular Biology. 16(1). 13–13. 6 indexed citations
4.
Ardestani, Amin, Federico Paroni, Zahra Azizi, et al.. (2014). MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes. Nature Medicine. 20(4). 385–397. 169 indexed citations
5.
Frogne, Thomas, Kathrine B. Sylvestersen, Stefan Kubicek, Michael L. Nielsen, & Jacob Hecksher‐Sørensen. (2012). Pdx1 Is Post-Translationally Modified In vivo and Serine 61 Is the Principal Site of Phosphorylation. PLoS ONE. 7(4). e35233–e35233. 14 indexed citations
6.
Emdal, Kristina B., et al.. (2009). Breast cancer cells can switch between estrogen receptor α and ErbB signaling and combined treatment against both signaling pathways postpones development of resistance. Breast Cancer Research and Treatment. 121(3). 601–613. 27 indexed citations
7.
Frogne, Thomas, Anne‐Vibeke Lænkholm, Maria Lyng, Katrine L. Henriksen, & Anne E. Lykkesfeldt. (2009). Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors. Breast Cancer Research. 11(1). R11–R11. 65 indexed citations
8.
Henriksen, Katrine L., et al.. (2008). Development of new predictive markers for endocrine therapy and resistance in breast cancer. Acta Oncologica. 47(4). 795–801. 2 indexed citations
9.
Frogne, Thomas, Rikke Vicki Benjaminsen, Boe Sandahl Sørensen, et al.. (2008). Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant. Breast Cancer Research and Treatment. 114(2). 263–75. 130 indexed citations
10.
Yde, Christina W., Thomas Frogne, Anne E. Lykkesfeldt, et al.. (2007). Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT. Cancer Letters. 256(2). 229–237. 41 indexed citations
11.
Frogne, Thomas, et al.. (2005). Antiestrogen-resistant human breast cancer cells require activated Protein Kinase B/Akt for growth. Endocrine Related Cancer. 12(3). 599–614. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tongzhen Chen Breakdown of academic impact, for papers by Kevin J. Basile Breakdown of academic impact, for papers by Natacha Bohin Breakdown of academic impact, for papers by Marie-José Blivet-Van Eggelpoël Breakdown of academic impact, for papers by Huiying Zhi Breakdown of academic impact, for papers by Anne Chotteau‐Lelièvre Breakdown of academic impact, for papers by Kathryn M. Kinross Breakdown of academic impact, for papers by Yang‐Min Xie Breakdown of academic impact, for papers by Awad Shamma Breakdown of academic impact, for papers by Prasad Kanteti
Rankless by CCL
2026